{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:03:21Z","timestamp":1787321001022,"version":"build-2736575974"},"reference-count":169,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1053\/j.ajkd.2012.09.020","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T02:02:14Z","timestamp":1357264934000},"page":"809-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Kidney Complications of Hematopoietic Stem Cell Transplantation"],"prefix":"10.1053","volume":"61","author":[{"given":"Neeraj","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"McNeely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvinder","family":"Bhinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad H.","family":"Rovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Shidham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1681\/ASN.2004100843","article-title":"Renal failure associated with cancer and its treatment: an update","volume":"16","author":"Humphreys","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib2","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1046\/j.1523-1755.2003.00936.x","article-title":"Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis","volume":"63","author":"Fadia","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib3","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/ki.1996.405","article-title":"Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer","volume":"50","author":"Merouani","year":"1996","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2012.09.020_bib4","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/01.ASN.0000129981.50357.1C","article-title":"Acute renal failure after nonmyeloablative hematopoietic cell transplantation","volume":"15","author":"Parikh","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1704144","article-title":"Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients","volume":"32","author":"Hahn","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ki.1994.417","article-title":"Acute renal failure in the setting of bone marrow transplantation","volume":"46","author":"Zager","year":"1994","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib7","first-page":"659","article-title":"Acute tumor lysis syndrome complicating conditioning therapy for bone marrow transplantation in a patient with chronic lymphocytic leukemia","volume":"13","author":"Nomdedeu","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib8","first-page":"235","article-title":"Radiation induced acute tumor lysis syndrome in the bone marrow transplant setting","volume":"8","author":"Fleming","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2012.09.020_bib9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bmt.1704025","article-title":"Peracute onset of severe tumor lysis syndrome immediately after 4 Gy fractionated TBI as part of reduced intensity preparative regimen in a patient with T-ALL with high tumor burden","volume":"31","author":"Linck","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"10.1053\/j.ajkd.2012.09.020_bib10","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1053\/j.ajkd.2012.09.020_bib11","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bmt.1705899","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies","volume":"41","author":"Ho","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2012.09.020_bib13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00007890-200211150-00018","article-title":"Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients","volume":"74","author":"Pihusch","year":"2002","journal-title":"Transplantation"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.imbio.2011.07.028","article-title":"Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome","volume":"217","author":"Kerr","year":"2012","journal-title":"Immunobiology"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib15","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00467-010-1522-1","article-title":"Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction","volume":"25","author":"Zoja","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00062752-200109000-00004","article-title":"Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"8","author":"Medina","year":"2001","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib17","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non-enteropathic hemolytic uremic syndrome: causes and short-term course","volume":"43","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00277-003-0608-2","article-title":"Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma\/leukemia before and after introduction of prophylactic use of urate oxidase","volume":"82","author":"Wossmann","year":"2003","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7150\/ijms.4.83","article-title":"Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout","volume":"4","author":"Cammalleri","year":"2007","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000082016","article-title":"Phosphate kinetics during different dialysis modalities","volume":"23","author":"Ratanarat","year":"2005","journal-title":"Blood Purif"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib22","first-page":"795","article-title":"Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III\/defibrotide therapy","volume":"91","author":"Haussmann","year":"2006","journal-title":"Haematologica"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","article-title":"A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation","volume":"84","author":"Bearman","year":"1993","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib24","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib25","first-page":"1122","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study","volume":"111","author":"Chopra","year":"2000","journal-title":"Br J Haematol"},{"issue":"13","key":"10.1053\/j.ajkd.2012.09.020_bib26","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","article-title":"Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome","volume":"100","author":"Richardson","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.ajkd.2012.09.020_bib27","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9823","key":"10.1053\/j.ajkd.2012.09.020_bib28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib29","first-page":"148","article-title":"The hemolytic uremic syndrome of childhood and its variants","volume":"24","author":"Kaplan","year":"1987","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib30","doi-asserted-by":"crossref","first-page":"c37","DOI":"10.1159\/000320901","article-title":"Haemolytic uraemic syndrome","volume":"118","author":"Kavanagh","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMc0808527","article-title":"Eculizumab for atypical hemolytic-uremic syndrome","volume":"360","author":"Nurnberger","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000188587","article-title":"Bone marrow transplant nephropathy: radiation nephritis revisited","volume":"70","author":"Cohen","year":"1995","journal-title":"Nephron"},{"issue":"12","key":"10.1053\/j.ajkd.2012.09.020_bib33","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1111\/j.1600-6143.2011.03719.x","article-title":"Histological characteristics of calcineurin inhibitor toxicity\u2014there is no such thing as specificity!","volume":"11","author":"Mengel","year":"2011","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2141.2005.05728.x","article-title":"Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation","volume":"131","author":"Srinivasan","year":"2005","journal-title":"Br J Haematol"},{"issue":"19","key":"10.1053\/j.ajkd.2012.09.020_bib35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197905103001901","article-title":"Aberrations of suppressor T cells in human graft-versus-host disease","volume":"300","author":"Reinherz","year":"1979","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199602013340501","article-title":"Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation","volume":"334","author":"Goulmy","year":"1996","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1365-2141.2001.03035.x","article-title":"Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor","volume":"114","author":"Balduini","year":"2001","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib38","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2004-12-4726","article-title":"Leukocyte migration and graft-versus-host disease","volume":"105","author":"Wysocki","year":"2005","journal-title":"Blood"},{"issue":"24","key":"10.1053\/j.ajkd.2012.09.020_bib39","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1182\/blood-2008-10-161638","article-title":"The role of B cells in the pathogenesis of graft-versus-host disease","volume":"114","author":"Shimabukuro-Vornhagen","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000046273","article-title":"Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation","volume":"21","author":"Lin","year":"2001","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.ajkd.2005.01.003","article-title":"Nephrotic syndrome in patients with peripheral blood stem cell transplant","volume":"45","author":"Rao","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2215\/CJN.00380705","article-title":"Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?","volume":"1","author":"Brukamp","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s10157-010-0337-5","article-title":"Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Kim","year":"2010","journal-title":"Clin Exp Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2012.09.020_bib44","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.humpath.2006.07.011","article-title":"Focal segmental glomerulosclerosis after membranous glomerulonephritis in remission: temporal diversity of glomerulopathy after bone marrow transplantation","volume":"37","author":"Chan","year":"2006","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib45","first-page":"495","article-title":"Nephrotic syndrome resulting from focal segmental glomerulosclerosis in a peripheral blood stem cell transplant patient","volume":"20","author":"Heras","year":"2007","journal-title":"J Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.2005.02838.x","article-title":"Possible role of autoantibodies against nephrin in an experimental model of chronic graft-versus-host disease","volume":"141","author":"Nagahama","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1053\/j.ajkd.2012.09.020_bib47","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1440-1827.2011.02704.x","article-title":"Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"61","author":"Mii","year":"2011","journal-title":"Pathol Int"},{"issue":"8","key":"10.1053\/j.ajkd.2012.09.020_bib48","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1182\/blood.V77.8.1837.1837","article-title":"Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies","volume":"77","author":"Rabinowe","year":"1991","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib49","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1159\/000187412","article-title":"Clinical course of late-onset bone marrow transplant nephropathy","volume":"64","author":"Cohen","year":"1993","journal-title":"Nephron"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib50","first-page":"339","article-title":"Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?","volume":"3","author":"Chappell","year":"1988","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2012.09.020_bib51","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1093\/ndt\/11.7.1332","article-title":"Haemolytic uraemic syndrome following bone marrow transplantation","volume":"11","author":"Verburgh","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1701830","article-title":"Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation","volume":"24","author":"Iacopino","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2012.09.020_bib53","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib54","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0272-6386(89)80054-X","article-title":"Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients","volume":"13","author":"Zager","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2012.09.020_bib55","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00467-003-1146-9","article-title":"Renal function following hematological stem cell transplantation in childhood","volume":"18","author":"Patzer","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib56","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.ajkd.2012.09.020_bib57","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1700767","article-title":"Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease","volume":"19","author":"Salat","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2141.2006.06126.x","article-title":"Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation","volume":"134","author":"Peyvandi","year":"2006","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4065\/77.4.323","article-title":"Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects","volume":"77","author":"Raife","year":"2002","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib60","first-page":"39","article-title":"Changes in the natural anticoagulants following bone marrow transplantation","volume":"5","author":"Harper","year":"1990","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib61","first-page":"126","article-title":"Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"34","author":"Schriber","year":"1997","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bmt.1703312","article-title":"Renal function after autologous bone marrow transplantation in children: a long-term prospective study","volume":"29","author":"Frisk","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib63","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s00066-005-1405-8","article-title":"Renal dysfunction after total-body irradiation","volume":"181","author":"Igaki","year":"2005","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib64","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1523-1755.2000.00241.x","article-title":"Radiation nephropathy after bone marrow transplantation","volume":"58","author":"Cohen","year":"2000","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib65","first-page":"405","article-title":"Hemolytic uremic syndrome following bone marrow transplantation","volume":"7","author":"Juckett","year":"1991","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib66","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000168610","article-title":"Hemolytic uremic syndrome after bone marrow transplantation without total body irradiation","volume":"13","author":"Oursler","year":"1993","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib67","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1667\/0033-7587(2001)155[0481:TROTTI]2.0.CO;2","article-title":"The role of the tubulointerstitium in radiation-induced renal fibrosis","volume":"155","author":"Robbins","year":"2001","journal-title":"Radiat Res"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib68","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2307\/3574561","article-title":"Interrelationship between the early inflammatory response and subsequent fibrosis after radiation exposure","volume":"72","author":"Ullrich","year":"1977","journal-title":"Radiat Res"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib69","first-page":"507","article-title":"Radiation nephritis: acute changes following high dose of radiation","volume":"54","author":"Madrazo","year":"1969","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0360-3016(88)90352-5","article-title":"Late onset of renal dysfunction in survivors of bone marrow transplantation","volume":"15","author":"Tarbell","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1053\/j.ajkd.2012.09.020_bib71","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0360-3016(83)90366-8","article-title":"Total body irradiation as preparation for bone marrow transplantation in treatment of acute leukemia and aplastic anemia","volume":"9","author":"Serota","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib72","doi-asserted-by":"crossref","first-page":"987","DOI":"10.7326\/0003-4819-49-5-987","article-title":"Radiation injury and marrow replacement: factors affecting survival of the host and the homograft","volume":"49","author":"Ferrebee","year":"1958","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2012.09.020_bib73","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1148\/84.3.452","article-title":"A four-year experience with total-body irradiation","volume":"84","author":"Jacobs","year":"1965","journal-title":"Radiology"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib74","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/1097-0142(19910601)67:11<2795::AID-CNCR2820671114>3.0.CO;2-D","article-title":"Late renal dysfunction in adult survivors of bone marrow transplantation","volume":"67","author":"Lawton","year":"1991","journal-title":"Cancer"},{"key":"10.1053\/j.ajkd.2012.09.020_bib75","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1259\/bjr\/18309193","article-title":"Radiation-induced multi-organ involvement and failure: the contribution of radiation effects on the renal system","volume":"27","author":"Moulder","year":"2005","journal-title":"BJR Suppl"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib76","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0360-3016(02)03039-0","article-title":"Renal toxicity after total body irradiation","volume":"54","author":"Borg","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib77","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00066-009-2022-8","article-title":"Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT)","volume":"185","author":"Gerstein","year":"2009","journal-title":"Strahlenther Onkol"},{"issue":"86","key":"10.1053\/j.ajkd.2012.09.020_bib78","first-page":"215","article-title":"Radiation nephritis","volume":"22","author":"Luxton","year":"1953","journal-title":"Q J Med"},{"key":"10.1053\/j.ajkd.2012.09.020_bib79","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/02841866409134143","article-title":"Radiation nephritis","volume":"2","author":"Luxton","year":"1964","journal-title":"Acta Radiol Ther Phys Biol"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib80","first-page":"283","article-title":"Radiation nephritis","volume":"34","author":"Madrazo","year":"1976","journal-title":"Lab Invest"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib81","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.1996.14.2.579","article-title":"Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease","volume":"14","author":"Miralbell","year":"1996","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib82","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0360-3016(94)00428-N","article-title":"Clinical radiation nephropathy","volume":"31","author":"Cassady","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1053\/j.ajkd.2012.09.020_bib83","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1182\/blood-2010-06-284349","article-title":"Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases","volume":"117","author":"Schulz","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.ajkd.2012.09.020_bib84","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/sj.bmt.1705182","article-title":"Radioimmunoconjugates in acute leukemia treatment: the future is radiant","volume":"36","author":"Kotzerke","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib85","first-page":"278","article-title":"Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation","volume":"47","author":"Zenz","year":"2006","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib86","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1586\/14737140.6.3.445","article-title":"Review of clinical radioimmunotherapy","volume":"6","author":"Pohlman","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib87","first-page":"322","article-title":"Current status and perspectives in alpha radioimmunotherapy","volume":"50","author":"Cherel","year":"2006","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib88","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1158\/0008-5472.CAN-10-1186","article-title":"Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN)","volume":"71","author":"Wild","year":"2011","journal-title":"Cancer Res"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2967\/jnumed.107.046938","article-title":"Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6","volume":"49","author":"Zalutsky","year":"2008","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib90","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ijrobp.2005.11.036","article-title":"Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys","volume":"64","author":"Jaggi","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib91","first-page":"359","article-title":"Clinical aspects of radiation nephropathy","volume":"19","author":"Breitz","year":"2004","journal-title":"Cancer Biother Radiopharm"},{"issue":"9","key":"10.1053\/j.ajkd.2012.09.020_bib92","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1681\/ASN.2004110945","article-title":"Renal tubulointerstitial changes after internal irradiation with alpha-particle-emitting actinium daughters","volume":"16","author":"Jaggi","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib93","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/1097-0142(197506)35:6<1678::AID-CNCR2820350629>3.0.CO;2-K","article-title":"Modification of radiation injury to normal tissues by chemotherapeutic agents","volume":"35","author":"Phillips","year":"1975","journal-title":"Cancer"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00007890-198601000-00013","article-title":"Radiation nephritis following total-body irradiation and cyclophosphamide in preparation for bone marrow transplantation","volume":"41","author":"Bergstein","year":"1986","journal-title":"Transplantation"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib95","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0272-6386(89)80214-8","article-title":"Hemolytic uremic syndrome following bone marrow transplantation: a case report and review of the literature","volume":"14","author":"Loomis","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"18","key":"10.1053\/j.ajkd.2012.09.020_bib96","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","article-title":"Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors","volume":"45","author":"Skinner","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib97","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bmt.1702812","article-title":"Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy","volume":"27","author":"Vantelon","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib98","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0360-3016(94)90108-2","article-title":"Effect of nephrotoxic drugs on the development of radiation nephropathy after bone marrow transplantation","volume":"28","author":"Lawton","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.ajkd.2012.09.020_bib99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-0-387-78580-6_13","article-title":"Radioimmunoconjugates in hematopoietic stem cell transplantation","volume":"144","author":"Gopal","year":"2009","journal-title":"Cancer Treat Res"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib100","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V94.4.1237","article-title":"Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome","volume":"94","author":"Matthews","year":"1999","journal-title":"Blood"},{"issue":"9","key":"10.1053\/j.ajkd.2012.09.020_bib101","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s004670050693","article-title":"Possible association of retinoic acid with bone marrow transplant nephropathy","volume":"13","author":"Turman","year":"1999","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2012.09.020_bib102","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/sj.bmt.1702003","article-title":"Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children","volume":"24","author":"Matsuda","year":"1999","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib103","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1681\/ASN.V81166","article-title":"Bone marrow transplant nephropathy: a case report and review of the literature","volume":"8","author":"Cruz","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib104","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1440-1827.2010.02608.x","article-title":"Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation","volume":"61","author":"Mii","year":"2011","journal-title":"Pathol Int"},{"issue":"10","key":"10.1053\/j.ajkd.2012.09.020_bib106","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.bbmt.2011.02.012","article-title":"Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation","volume":"17","author":"Haines","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib107","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib108","first-page":"54","article-title":"De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine","volume":"98","author":"Van Buren","year":"1985","journal-title":"Surgery"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib109","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.transproceed.2010.02.029","article-title":"Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience","volume":"42","author":"Said","year":"2010","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib111","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.02699.x","article-title":"The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation","volume":"113","author":"Fuge","year":"2001","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1053\/j.ajkd.2012.09.020_bib112","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.bmt.1705643","article-title":"Significant increase in end-stage renal disease after hematopoietic stem cell transplantation","volume":"39","author":"Cohen","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib113","first-page":"495","article-title":"Thrombotic microangiopathy following bone marrow transplantation","volume":"14","author":"Pettitt","year":"1994","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib114","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bmt.1702849","article-title":"Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes","volume":"27","author":"Roy","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2012.09.020_bib115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.bmt.1701022","article-title":"Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation","volume":"20","author":"Lawton","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib116","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Haematologica"},{"issue":"8","key":"10.1053\/j.ajkd.2012.09.020_bib117","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib118","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","article-title":"Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study","volume":"85","author":"Siami","year":"2008","journal-title":"Transplantation"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib119","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1083-8791(03)00243-X","article-title":"Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation","volume":"9","author":"El-Seisi","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib120","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/bmt.2010.182","article-title":"Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT","volume":"46","author":"Laskin","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2012.09.020_bib121","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib122","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/01.ASN.0000060805.04118.4C","article-title":"Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura","volume":"14","author":"Tsai","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib123","first-page":"37","article-title":"Radiation nephritis","volume":"61","author":"Madrazo","year":"1970","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib124","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ki.1989.132","article-title":"Delayed renal failure with extensive mesangiolysis following bone marrow transplantation","volume":"35","author":"Antignac","year":"1989","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0046-8177(89)90139-1","article-title":"Mesangiolytic glomerulopathy in a bone marrow allograft recipient","volume":"20","author":"Iskandar","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1053\/j.ajkd.2012.09.020_bib126","first-page":"707","article-title":"Effects of irradiation on canine kidney","volume":"44","author":"Mostofi","year":"1964","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib127","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1182\/blood.V93.11.3798","article-title":"von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura","volume":"93","author":"van der Plas","year":"1999","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib128","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1182\/blood-2002-02-0344","article-title":"von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura","volume":"100","author":"Bianchi","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.ajkd.2012.09.020_bib129","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jca.2920060104","article-title":"Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura associated with bone marrow transplantation","volume":"6","author":"Silva","year":"1991","journal-title":"J Clin Apher"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P","article-title":"Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura","volume":"57","author":"Chow","year":"1998","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib132","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0049-3848(85)90180-X","article-title":"Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen","volume":"38","author":"Asada","year":"1985","journal-title":"Thromb Res"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib133","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/sj.thj.6200127","article-title":"Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy","volume":"2","author":"Arai","year":"2001","journal-title":"Hematol J"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib134","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/00006450-200105000-00008","article-title":"von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome","volume":"49","author":"Tsai","year":"2001","journal-title":"Pediatr Res"},{"issue":"1-2","key":"10.1053\/j.ajkd.2012.09.020_bib135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib136","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bbmt.2005.07.012","article-title":"Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children","volume":"11","author":"Hale","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib137","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00007890-198707000-00027","article-title":"Cyclosporine-induced acute renal dysfunction in the rat","volume":"44","author":"English","year":"1987","journal-title":"Transplantation"},{"issue":"9","key":"10.1053\/j.ajkd.2012.09.020_bib138","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1600-6143.2010.03224.x","article-title":"Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues","volume":"10","author":"Schwarz","year":"2010","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib139","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198409133111103","article-title":"Cyclosporine-associated chronic nephropathy","volume":"311","author":"Myers","year":"1984","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib140","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.1988.38","article-title":"The long-term course of cyclosporine-associated chronic nephropathy","volume":"33","author":"Myers","year":"1988","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2012.09.020_bib141","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1681\/ASN.V22s45","article-title":"Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury","volume":"2","author":"Myers","year":"1991","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2012.09.020_bib142","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib143","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host syndrome in man","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib144","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1034\/j.1399-0012.1999.130409.x","article-title":"Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression","volume":"13","author":"Butcher","year":"1999","journal-title":"Clin Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V57.2.267.267","article-title":"Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression","volume":"57","author":"Sullivan","year":"1981","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib146","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/modpathol.3801011","article-title":"Renal pathology in hematopoietic cell transplantation recipients","volume":"21","author":"Troxell","year":"2008","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib147","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00007890-198811000-00014","article-title":"Chronic injury of human renal microvessels with low-dose cyclosporine therapy","volume":"46","author":"Myers","year":"1988","journal-title":"Transplantation"},{"issue":"8","key":"10.1053\/j.ajkd.2012.09.020_bib148","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbmt.2009.04.004","article-title":"Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality","volume":"15","author":"Sabry","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib149","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood-2003-12-4241","article-title":"Tumor necrosis factor-alpha blockade for the treatment of acute GVHD","volume":"104","author":"Couriel","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib150","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000045085","article-title":"End-stage renal disease (ESRD) after bone marrow transplantation: poor survival compar ed to other causes of ESRD","volume":"79","author":"Cohen","year":"1998","journal-title":"Nephron"},{"issue":"7","key":"10.1053\/j.ajkd.2012.09.020_bib151","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbmt.2004.03.002","article-title":"Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced","volume":"10","author":"Shimoni","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"20","key":"10.1053\/j.ajkd.2012.09.020_bib152","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2010-08-300541","article-title":"American Society of Hematology\/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer","volume":"116","author":"Rizzo","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.ajkd.2012.09.020_bib153","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jpainsymman.2003.06.010","article-title":"The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events","volume":"27","author":"Rosenzweig","year":"2004","journal-title":"J Pain Symptom Manage"},{"issue":"14","key":"10.1053\/j.ajkd.2012.09.020_bib154","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jama.2010.359","article-title":"New oversight put in place for physicians giving anemia drugs to patients with cancer","volume":"303","author":"Mitka","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ajkd.2012.09.020_bib155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1667\/0033-7587(2002)157[0393:AIBRRI]2.0.CO;2","article-title":"Angiotensin II blockade reduces radiation-induced proliferation in experimental radiation nephropathy","volume":"157","author":"Moulder","year":"2002","journal-title":"Radiat Res"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib156","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-2143(97)90008-1","article-title":"Successful brief captopril treatment in experimental radiation nephropathy","volume":"129","author":"Cohen","year":"1997","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1053\/j.ajkd.2012.09.020_bib157","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0360-3016(02)03793-8","article-title":"Successful treatment of radiation nephropathy with angiotensin II blockade","volume":"55","author":"Cohen","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib158","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1703710","article-title":"Transplantation-associated thrombotic microangiopathy: twenty-two years later","volume":"30","author":"Daly","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib159","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib160","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1053\/j.ajkd.2012.09.020_bib161","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2012.09.020_bib162","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703226","article-title":"Oral eicosapentaenoic acid for complications of bone marrow transplantation","volume":"28","author":"Takatsuka","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib163","doi-asserted-by":"crossref","first-page":"954","DOI":"10.7326\/0003-4819-114-11-954","article-title":"Immunologic tolerance to renal allografts after bone marrow transplants from the same donors","volume":"114","author":"Sayegh","year":"1991","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib164","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-199809000-00005","article-title":"Outcomes of recipients of both bone marrow and solid organ transplants","volume":"77","author":"Dey","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1053\/j.ajkd.2012.09.020_bib165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1034\/j.1600-6143.2003.00015.x","article-title":"Outcomes of renal transplantation following bone marrow transplantation","volume":"3","author":"Hamawi","year":"2003","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2012.09.020_bib166","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-3046.2004.00208.x","article-title":"Successful renal transplantation following prior bone marrow transplantation in pediatric patients","volume":"8","author":"Thomas","year":"2004","journal-title":"Pediatr Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2012.09.020_bib167","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/bmt.2008.377","article-title":"Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study","volume":"43","author":"Schleuning","year":"2009","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2012.09.020_bib168","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/bmt.2012.45","article-title":"Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation","volume":"47","author":"Ruutu","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.ajkd.2012.09.020_bib169","first-page":"87","article-title":"2010 Report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders","author":"Pasquini","year":"2010","journal-title":"Clin Transpl"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612014758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638612014758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:08:42Z","timestamp":1759457322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638612014758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":169,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0272638612014758"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.09.020","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney Complications of Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2012.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}